Literature DB >> 8437234

Calcium ions are required for cell fusion mediated by the CD4-human immunodeficiency virus type 1 envelope glycoprotein interaction.

D S Dimitrov1, C C Broder, E A Berger, R Blumenthal.   

Abstract

Calcium ions are required for fusion of a wide variety of artificial and biological membranes. To examine the role of calcium ions for cell fusion mediated by interactions between CD4 and the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (gp120-gp41), we used two experimental systems: (i) cells expressing gp120-gp41 and its receptor CD4, both encoded by recombinant vaccinia viruses, and (ii) chronically infected cells producing low levels of HIV-1. Fusion was measured by counting the number of syncytia and by monitoring the redistribution of fluorescence dyes by video microscopy. Syncytia did not form in solutions without calcium ions. Addition of calcium ions partially restored the formation of syncytia. EDTA and EGTA [ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid] blocked syncytium formation in culture media containing calcium ions. Membrane fusion as monitored by fluorescence dye redistribution also required calcium ions. Cell fusion increased with an increase in calcium ion concentration from 100 microM to 10 mM but was not affected by magnesium ions in the concentration range from 0 to 30 mM. Fibrinogen and fibronectin did not promote fusion in the absence or presence of Ca2+. Binding of soluble CD4 to gp120-gp41-expressing cells was not affected by Ca2+ and Mg2+. We conclude that Ca2+ is involved in postbinding steps in cell fusion mediated by the CD4-HIV-1 envelope glycoprotein interaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8437234      PMCID: PMC237536     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Studies on membrane fusion. III. The role of calcium-induced phase changes.

Authors:  D Papahadjopoulos; W J Vail; C Newton; S Nir; K Jacobson; G Poste; R Lazo
Journal:  Biochim Biophys Acta       Date:  1977-03-17

2.  Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles.

Authors:  H Sato; J Orenstein; D Dimitrov; M Martin
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

3.  Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  D S Dimitrov; K Hillman; J Manischewitz; R Blumenthal; H Golding
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein.

Authors:  M A Markwell; A Portner; A L Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

5.  AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen.

Authors:  J D Lifson; G R Reyes; M S McGrath; B S Stein; E G Engleman
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

6.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.

Authors:  D Klatzmann; E Champagne; S Chamaret; J Gruest; D Guetard; T Hercend; J C Gluckman; L Montagnier
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

7.  Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.

Authors:  E A Berger; J D Lifson; L E Eiden
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

8.  Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes.

Authors:  D S Dimitrov; H Golding; R Blumenthal
Journal:  AIDS Res Hum Retroviruses       Date:  1991-10       Impact factor: 2.205

9.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.

Authors:  Q J Sattentau; J P Moore
Journal:  J Exp Med       Date:  1991-08-01       Impact factor: 14.307

View more
  20 in total

1.  Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.

Authors:  B J Doranz; S S Baik; R W Doms
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Inhibition of human immunodeficiency virus type 1 production in infected peripheral blood mononuclear cells by human leukocyte antigen class I-specific antibodies: evidence for a novel antiviral mechanism.

Authors:  L Briant; M Benkirane; M Girard; M Hirn; C Iosef; C Devaux
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Alteration of intracellular potassium and sodium concentrations correlates with induction of cytopathic effects by human immunodeficiency virus.

Authors:  T G Voss; C D Fermin; J A Levy; S Vigh; B Choi; R F Garry
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.

Authors:  V Litwin; K A Nagashima; A M Ryder; C H Chang; J M Carver; W C Olson; M Alizon; K W Hasel; P J Maddon; G P Allaway
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Identification of CXCR4 domains that support coreceptor and chemokine receptor functions.

Authors:  B J Doranz; M J Orsini; J D Turner; T L Hoffman; J F Berson; J A Hoxie; S C Peiper; L F Brass; R W Doms
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

6.  Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1.

Authors:  G E Rabut; J A Konner; F Kajumo; J P Moore; T Dragic
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Identification of a Ca2+-binding domain in the rubella virus nonstructural protease.

Authors:  Yubin Zhou; Wen-Pin Tzeng; Wei Yang; Yumei Zhou; Yiming Ye; Hsiau-wei Lee; Teryl K Frey; Jenny Yang
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

8.  Ex vivo comparison of microbicide efficacies for preventing HIV-1 genomic integration in intraepithelial vaginal cells.

Authors:  M Juliana McElrath; Lamar Ballweber; Andrew Terker; Allison Kreger; Polachai Sakchalathorn; Barry Robinson; Michael Fialkow; Gretchen Lentz; Florian Hladik
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

9.  Influence of calcium on lipid mixing mediated by influenza hemagglutinin.

Authors:  Mikhail A Zhukovsky; Ingrid Markovic; Austin L Bailey
Journal:  Arch Biochem Biophys       Date:  2007-05-25       Impact factor: 4.013

10.  The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.

Authors:  H Golding; J Manischewitz; L Vujcic; R Blumenthal; D S Dimitrov
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.